AMICUS THERAPEUTICS, INC. - FOLD

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 14, 2026 SCHEDULE 13G Barclays PLC 5.65% 17,755,672 View
May 11, 2026 SCHEDULE 13G THE GOLDMAN SACHS GROUP, INC. 5.3% 16,782,163 View
May 11, 2026 SCHEDULE 13G GOLDMAN SACHS & CO. LLC 5.3% 16,782,163 View
May 07, 2026 SCHEDULE 13G UBS Group AG 5.5% 17,141,817 View
May 01, 2026 SCHEDULE 13G Glazer Capital, LLC 0.0% 0 View
May 01, 2026 SCHEDULE 13G Paul J. Glazer 0.0% 0 View
Apr 29, 2026 SCHEDULE 13G Vanguard Capital Management 5.2% 16,350,837 View
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Management Group LLP 0.4% 1,373,867 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Group Holdings LLP 0.4% 1,373,867 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Investment Advisors Holdings LLP 0.4% 1,373,867 View
Feb 09, 2026 SCHEDULE 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3.4% 10,627,717 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.